News
ESTA
47.38
-9.87%
-5.19
Establishment Labs Announces Participation in The Aesthetic Meeting 2024
Establishment Labs Holdings Inc. Is a global medical technology company dedicated to improving women’s health and wellness. The Aesthetic Meeting 2024 is being held May 2-5 in Vancouver, BC Canada. The Company's Motiva silicone gel-filled implants are currently not approved for commercial distribution in the United States.
Barchart · 4d ago
Weekly Report: what happened at ESTA last week (0408-0412)?
Weekly Report · 6d ago
Weekly Report: what happened at ESTA last week (0401-0405)?
Weekly Report · 04/08 10:25
Establishment Labs Is Maintained at Buy by Citigroup
Dow Jones · 04/03 15:56
Citigroup Maintains Buy on Establishment Labs Hldgs, Raises Price Target to $60
Benzinga · 04/03 15:46
Analysts Offer Insights on Healthcare Companies: Establishment Labs Holdings (ESTA) and Gritstone Oncology (GRTS)
TipRanks · 04/03 09:32
Establishment Labs Hldgs Inc: Statement of changes in beneficial ownership of securities
Press release · 04/02 21:20
Key Takeaways From Establishment Labs Hldgs Analyst Ratings
Establishment Labs Hldgs is a medical technology company engaged in offering silicone-filled breast and body shaping implants. The average 12-month price target for the company is $56.25. The company's revenue growth rate is lower than its peers in the Health Care sector. Four analysts have recently released ratings for Establishment Labs Hlgs.
Benzinga · 04/01 14:00
Mizuho Reiterates Buy on Establishment Labs Hldgs, Raises Price Target to $65
Benzinga · 04/01 13:51
Establishment Labs Is Maintained at Buy by Mizuho
Dow Jones · 04/01 11:59
Establishment Labs Price Target Raised to $65.00/Share From $50.00 by Mizuho
Dow Jones · 04/01 11:59
Mizuho Maintains Buy on Establishment Labs Hldgs, Raises Price Target to $65
Benzinga · 04/01 11:48
Weekly Report: what happened at ESTA last week (0325-0329)?
Weekly Report · 04/01 10:24
Weekly Report: what happened at ESTA last week (0318-0322)?
Weekly Report · 03/25 10:26
Establishment Labs Poised for Robust Growth with Motiva Expansion and Upcoming Market Entries
TipRanks · 03/20 04:15
Weekly Report: what happened at ESTA last week (0311-0315)?
Weekly Report · 03/18 10:24
Establishment Labs Price Target Raised to $60.00/Share From $50.00 by TD Cowen
Dow Jones · 03/12 15:44
Establishment Labs Is Maintained at Outperform by TD Cowen
Dow Jones · 03/12 15:44
TD Cowen Maintains Outperform on Establishment Labs Hldgs, Raises Price Target to $60
Benzinga · 03/12 15:33
Buy Rating Affirmed for Establishment Labs on Positive FDA Approval Progress and Strong GMP Preparedness
TD Cowen maintained a Buy rating on Establishment Labs Holdings (ESTA) with a price target of $60.00. The company is in the process of obtaining FDA approval for its silicone breast implants. The firm is expected to receive a Good Manufacturing Practice inspection date soon.
TipRanks · 03/12 08:15
More
Webull provides a variety of real-time ESTA stock news. You can receive the latest news about Establishment Labs Hldgs Inc through multiple platforms. This information may help you make smarter investment decisions.
About ESTA
Establishment Labs Holdings Inc. is Costa Rica-based medical technology and aesthetics company that is focused on women's health reconstruction market. The Company is engaged in the designing, developing, manufacturing and marketing of product portfolio consisting of silicone-filled breast and body shaping implants. The main activities are conducted at two manufacturing facilities in Costa Rica including Motiva Implants brand sold in over 80 countries globally through a combination of distributors and direct sales to customers.